Literature DB >> 6466555

Studies on experimental chronic active hepatitis in the rabbit. I. Induction of the disease by immunization with muscle as well as liver proteins.

R C Butler.   

Abstract

Rabbits given weekly injections of two human liver-specific proteins, one a cell membrane antigen known as LSP, the other a cytoplasmic protein known as LP2, in combination with complete Freund's adjuvant (CFA) developed chronic active hepatitis. Although this lesion persisted for at least 1 year in some animals, cirrhosis did not supervene. Chronic active hepatitis was also produced by injection of the membrane protein LSP in CFA, without LP2. Unexpectedly, injection of a human skeletal muscle extract in CFA also caused chronic active hepatitis. It is possible therefore that sensitization to antigens other than liver-specific proteins may play a part in the pathogenesis of chronic active hepatitis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6466555      PMCID: PMC2040991     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  11 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Studies on "liver-specific" antigens. I. Evaluation of the liver specificity of "LSP" and "LP-2".

Authors:  U J Behrens; F Paronetto
Journal:  Gastroenterology       Date:  1979-11       Impact factor: 22.682

3.  The role of myofibrillar fraction of skeletal muscle in the production of experimental polymyositis.

Authors:  D Manghani; T A Partridge; J C Sloper
Journal:  J Neurol Sci       Date:  1974-12       Impact factor: 3.181

4.  Experimental chronic active hepatitis in rabbits following immunization with human liver proteins.

Authors:  K H Büschenfelde; F K Kössling; P A Miescher
Journal:  Clin Exp Immunol       Date:  1972-05       Impact factor: 4.330

5.  Studies on the pathogenesis of experimental chronic active hepatitis in rabbits. I. Induction of the disease and protective effect of allogeneic liver specific proteins.

Authors:  K H Meyer zum Büschenfelde; U Hopf
Journal:  Br J Exp Pathol       Date:  1974-10

6.  Purification and characterization of human liver-specific membrane lipoprotein (LSP).

Authors:  I G McFarlane; B M Wojcicka; G M Zucker; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1977-03       Impact factor: 4.330

7.  Detection of antibodies directed against a liver-specific membrane lipoprotein in patients with acute and chronic active hepatitis.

Authors:  D M Jensen; I G McFarlane; B S Portmann; A L Eddleston; R Williams
Journal:  N Engl J Med       Date:  1978-07-06       Impact factor: 91.245

8.  Immunological reactions to liver-specific membrane lipoprotein (LSP) in experimental autoimmune liver disease in rabbits.

Authors:  R M Uibo; H J Helin; K J Krohn
Journal:  Clin Exp Immunol       Date:  1982-05       Impact factor: 4.330

9.  Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg-negative chronic active hepatitis.

Authors:  G M Vergani; D Vergani; P J Jenkins; B Portmann; A P Mowat; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1979-10       Impact factor: 4.330

10.  Histological and immunological investigation of liver-specific protein (LSP) immunized rabbits compared with patients with liver disease.

Authors:  C Feighery; G S McDonald; J F Greally; D G Weir
Journal:  Clin Exp Immunol       Date:  1981-07       Impact factor: 4.330

View more
  1 in total

1.  Studies on experimental chronic active hepatitis in the rabbit. II. Immunological findings.

Authors:  R C Butler
Journal:  Br J Exp Pathol       Date:  1984-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.